Benzinga | Mar 1, 2021 04:08PM EST

Travere Therapeutics Q4 EPS $(2.37) Down From $(0.70) YoY, Sales $50.98M Miss $51.66M Estimate

Travere Therapeutics (NASDAQ:TVTX) reported quarterly losses of $(2.37) per share. This is a 238.57 percent decrease over losses of $(0.70) per share from the same period last year. The company reported quarterly sales of $50.98 million which missed the analyst consensus estimate of $51.66 million by 1.31 percent. This is a 9.20 percent increase over sales of $46.69 million the same period last year.